Positive Results for TYSABRI

Two-year data from the AFFIRM Phase III monotherapy trial presented for the first time, showed that treatment with TYSBARI (natalizumab) led to a significant reduction in disability progression...

Working at Google = Fun!

Jen Fitzpatrick (Director, Engineering at Google) points out a video they've put together highlighting all the benefits of working at Google.

Siebel Appoints New CEO

The Board of Directors of Siebel Systems announced the appointment of veteran industry technology leader George T. Shaheen as the company's Chief Executive Officer, effective immediately.